文献速递脑血管病

深部脑刺激治疗卒中后疼痛的随机临床试验

Randomized clinical trial of deep brain stimulation for poststroke pain.
PubMed 文献 · Ann Neurol · 2017-01-01

这项前瞻性、双盲、随机、假手术对照交叉研究纳入10例卒中后疼痛综合征患者,靶向腹侧纹状体/内囊前肢(VS/ALIC)进行DBS。主要终点为50%患者疼痛残疾指数改善≥50%,结果主要和次要终点均为阴性,但多个与疼痛情感维度相关的指标出现显著差异,安全性可接受。

要点

  • VS/ALIC DBS在卒中后疼痛中主要终点阴性,但情感维度指标显著改善。
  • 研究为探索性小样本(10例,9例完成随机),安全性可接受。
  • 结果支持进一步研究靶向疼痛情感环路的神经调控疗法。

核心结论

  • VS/ALIC DBS调节疼痛情感维度代表慢性疼痛管理的范式转变。
  • 该探索性研究主要终点阴性,但多个疼痛情感维度指标显著改善且安全性可接受。
  • 作者认为结果值得进一步开展靶向疼痛情感维度的神经调控研究。

研究设计与样本

  • 前瞻性、双盲、随机、假手术对照、交叉研究,纳入10例卒中后疼痛综合征患者。
  • 双侧DBS术后1个月随机分入 active DBS 或假刺激3个月,随后交叉另一3个月。
  • 6个月盲法阶段后进入18个月开放刺激阶段。

主要发现

  • 9例完成随机化。
  • 主要和次要终点均为阴性。
  • 多个与疼痛情感维度相关指标出现显著差异,包括蒙哥马利-艾斯伯格抑郁量表、贝克抑郁量表、简式麦吉尔疼痛问卷情感疼痛评分指数。

关键数值与推荐

  • 主要终点:active DBS 组相比假刺激组,50%患者疼痛残疾指数改善≥50%。

临床怎么用

  • VS/ALIC DBS可能作为调节卒中后疼痛情感维度的探索性神经调控策略。
  • 临床决策需权衡主要终点阴性结果与情感维度改善及安全性。

局限性

  • 探索性小样本研究(10例入组,9例完成随机化)。
  • 主要和次要终点均为阴性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The experience with deep brain stimulation (DBS) for pain is largely based on uncontrolled studies targeting the somatosensory pathways, with mixed results. We hypothesized that targeting limbic neural pathways would modulate the affective sphere of pain and alleviate suffering. METHODS: We conducted a prospective, double-blinded, randomized, placebo-controlled, crossover study of DBS targeting the ventral striatum/anterior limb of the internal capsule (VS/ALIC) in 10 patients with poststroke pain syndrome. One month after bilateral DBS, patients were randomized to active DBS or sham for 3 months, followed by crossover for another 3-month period. The primary endpoint was a ≥50% improvement on the Pain Disability Index in 50% of patients with active DBS compared to sham. This 6-month blinded phase was followed by an 18-month open stimulation phase. RESULTS: Nine participants completed randomization. Although this trial was negative for its primary and secondary endpoints, we did observe significant differences in multiple outcome measures related to the affective sphere of pain (eg, Montgomery-Åsberg Depression Rating Scale, Beck Depression Inventory, Affective Pain Rating Index of the Short-Form McGill Pain Questionnaire). Fourteen serious adverse events were recorded and resolved. INTERPRETATION: VS/ALIC DBS to modulate the affective sphere of pain represents a paradigm shift in chronic pain management. Although this exploratory study was negative for its primary endpoint, VS/ALIC DBS demonstrated an acceptable safety profile and statistically significant improvements on multiple outcome measures related to the affective sphere of pain. Therefore, we believe these results justify further work on neuromodulation therapies targeting the affective sphere of pain. Ann Neurol 2017;81:653-663.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Lempka SF, Malone DA, Hu B, et al. Randomized clinical trial of deep brain stimulation for poststroke pain. Ann Neurol. 2017. PMID: 28380672. doi:10.1002/ana.24927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。